Placebo for ABT-869

DRUG2 trials

Sponsors

AbbVie (prior sponsor, Abbott)

Conditions

Advanced or Metastatic Non-Small Cell Lung CancerMetastatic Breast Cancer

Phase 2

Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer

CompletedNCT00645177

AbbVie (prior sponsor, Abbott)Metastatic Breast Cancer

Start: 2008-07-31End: 2009-12-31Updated: 2013-01-29

Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

CompletedNCT00716534

AbbVie (prior sponsor, Abbott)Advanced or Metastatic Non-Small Cell Lung Cancer

Start: 2008-06-30End: 2012-04-30Updated: 2013-04-29